The influence of adiposity and acute exercise on circulating hepatokines in normal-weight and overweight/obese men

Circulating Follistatin Is Liver-Derived and Regulated by the Glucagon-to-Insulin Ratio

(2016) Jakob S. Hansen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Exercise-Induced Secretion of FGF21 and Follistatin Are Blocked by Pancreatic Clamp and Impaired in Type 2 Diabetes

(2016) Jakob Schiøler Hansen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Endurance Exercise Reduces Hepatic Fat Content and Serum Fibroblast Growth Factor 21 Levels in Elderly Men

(2016) Hirokazu Taniguchi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Exercise-stimulated glucose uptake — regulation and implications for glycaemic control

(2016) Lykke Sylow et al.   Nature Reviews Endocrinology

Fetuin B Is a Secreted Hepatocyte Factor Linking Steatosis to Impaired Glucose Metabolism

(2015) Ruth C. Meex et al.   Cell Metabolism

Attenuated fibroblast growth factor 21 response to acute aerobic exercise in obese individuals

(2015) A.L. Slusher et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

LECT2 Functions as a Hepatokine That Links Obesity to Skeletal Muscle Insulin Resistance

(2014) Fei Lan et al.   DIABETES

High plasma fetuin-A levels are associated with metabolic syndrome among males but not females in a Japanese general population

(2014) Aya Obuchi et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Fetuin-A: a novel link between obesity and related complications

(2014) J F Trepanowski et al.   INTERNATIONAL JOURNAL OF OBESITY

Development of a Sol Particle Homogeneous Immunoassay for Measuring Full-Length Selenoprotein P in Human Serum

(2014) Mutsumi Tanaka et al.   JOURNAL OF CLINICAL LABORATORY ANALYSIS

Exercise-Induced Lowering of Fetuin-A May Increase Hepatic Insulin Sensitivity

(2014) Steven K. Malin et al.   MEDICINE AND SCIENCE IN SPORTS AND EXERCISE

Plasma follistatin is elevated in patients with type 2 diabetes: relationship to hyperglycemia, hyperinsulinemia, and systemic low-grade inflammation

(2013) J. Hansen et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Cellular Mechanisms by Which FGF21 Improves Insulin Sensitivity in Male Mice

(2013) João Paulo G. Camporez et al.   ENDOCRINOLOGY

Fetuin-A is linked to improved glucose tolerance after short-term exercise training in nonalcoholic fatty liver disease

(2013) Steven K. Malin et al.   JOURNAL OF APPLIED PHYSIOLOGY

Salsalate and Adiponectin Improve Palmitate-Induced Insulin Resistance via Inhibition of Selenoprotein P through the AMPK-FOXO1α Pathway

(2013) Tae Woo Jung et al.   PLoS One

Acute Exercise Induces FGF21 Expression in Mice and in Healthy Humans

(2013) Kook Hwan Kim et al.   PLoS One

Increased serum leukocyte cell-derived chemotaxin 2 (LECT2) levels in obesity and fatty liver

(2013) Okumura   BioScience Trends

Increased Selenoprotein P Levels in Subjects with Visceral Obesity and Nonalcoholic Fatty Liver Disease

(2013) Hae Yoon Choi et al.   Diabetes & Metabolism Journal

Activin A and cardiovascular disease in type 2 diabetes mellitus

(2012) Thor Ueland et al.   Diabetes & Vascular Disease Research

Endocrine fibroblast growth factors 15/19 and 21: from feast to famine

(2012) M. J. Potthoff et al.   GENES & DEVELOPMENT

Acute Bone Marker Responses to Whole-Body Vibration and Resistance Exercise in Young Women

(2012) Vanessa D. Sherk et al.   JOURNAL OF CLINICAL DENSITOMETRY

Serum fetuin-A is correlated with metabolic syndrome in middle-aged and elderly Chinese

(2011) Yu Xu et al.   ATHEROSCLEROSIS

High Plasma Level of Fibroblast Growth Factor 21 Is an Independent Predictor of Type 2 Diabetes: A 5.4-year population-based prospective study in Chinese subjects

(2011) C. Chen et al.   DIABETES CARE

Serum Selenoprotein P Levels in Patients with Type 2 Diabetes and Prediabetes: Implications for Insulin Resistance, Inflammation, and Atherosclerosis

(2011) S. J. Yang et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

A Liver-Derived Secretory Protein, Selenoprotein P, Causes Insulin Resistance

(2010) Hirofumi Misu et al.   Cell Metabolism

Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride

(2010) Huating Li et al.   JOURNAL OF HEPATOLOGY

The Obese Without Cardiometabolic Risk Factor Clustering and the Normal Weight With Cardiometabolic Risk Factor Clustering

(2008) Rachel P. Wildman   ARCHIVES OF INTERNAL MEDICINE

Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans

(2008) X. Zhang et al.   DIABETES

Obesity and Free Fatty Acids

(2008) Guenther Boden   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA